An alkylating agent of value against both hematologic malignancies and solid tumors.
Lomustine has been studied across 11 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 🛡️ Immunity, 🫁 Liver & Detox, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 58% of studies addressing this area.
This evidence profile for Lomustine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.